Navigation Links
Catalent Pharma Solutions Breaks Ground On A Major Expansion Of Its Winchester, Kentucky Controlled Release Manufacturing Facility
Date:6/12/2013

SOMERSET, N.J., June 12, 2013 /PRNewswire/ -- Catalent Pharma Solutions, a leading global drug delivery technology and advanced supply solutions company, has announced a major expansion of its controlled release drug manufacturing facility in Winchester, Kentucky. The company is to invest nearly $35 million to expand the 100,000 square-foot facility by almost 80,000 square feet of modern manufacturing space, and will add as many as 90 new employees at the expanded site. Construction will commence on June 12, 2013 with a ceremony led by Kentucky Governor Steve Beshear and Catalent President and CEO John Chiminski. Catalent expects to complete the expansion by October 2014, and will welcome customers to tour the facility at that time.

The Governor of the Commonwealth of Kentucky, Steve Beshear, made the following statement, "Catalent is making tremendous strides forward in Winchester, and we're excited to see such success for a global company in the Commonwealth. The numbers speak for themselves, with 90 new jobs and $35 million in investment, but this also shows the level of confidence that Catalent has in Kentucky's high quality workforce."

Opened in 1992, Catalent's Winchester facility has evolved into one of the industry's premier sites for advanced oral controlled-release drug formulation and manufacturing, launching over 100 products for Catalent's pharmaceutical and consumer health customers. As industry demand for innovative dose forms continues to increase, Catalent is responding through expansion of its manufacturing premises and continuous improvement of equipment and workflows. 

"Catalent is a fully integrated formulation, regulatory, and manufacturing solutions partner, helping pharmaceutical and consumer healthcare companies differentiate their products and reach markets faster," commented Steve Havel, General Manager of Catalent's Winchester facility. "The expanded Winchester facility will provide our customers with enhanced access to custom equipment capabilities and our market-leading controlled release solutions and technologies."

The Winchester expansion comes on the heels of several significant investments Catalent has made in advanced delivery technologies globally. "Catalent has continued to build on its global leadership in advanced drug development solutions and advanced delivery technologies with major recent investments in controlled release forms, including fluid bed capacity, OptiMelt hot melt extrusion, and OSDRC OptiDose advanced tableting technologies," noted Mr. Chiminski. "As with Winchester, Catalent continues to invest to meet the most critical needs of the industry, including recently announced inhalation facility expansion in North Carolina, our recently completed biologics expansion in Wisconsin, and our two new ventures in China, which will focus on softgel technologies and clinical trial supplies."

To learn more about Catalent's modified release technologies, please visit http://www.catalent.com/index.php/delivery.

Notes for Editors

OSDrC is a registered trademark of Sanwa KK Co., Ltd. and OptiDose is a trademark of Catalent Pharma Solutions.

About Catalent

Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products.  With over 75 years serving the industry, Catalent has proven expertise in bringing more products to market faster, enhancing product performance and ensuring reliable product supply.  Catalent employs more than 8,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and generates more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, NJ. For more information, visit www.catalent.com.

more products. better treatments. reliably supplied.™ 


'/>"/>
SOURCE Catalent Pharma Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Catalent Pharma Solutions, Inc. Announces Increase In Tender Cap For Its Cash Tender Offer For Its 9-1/2%/10-1/4% Senior PIK-Election Notes Due 2015
2. Catalent Pharma Solutions, Inc. Announces Cash Tender Offer for up to $250 Million of Its 9-1/2%/10-1/4% Senior PIK-Election Notes due 2015
3. Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions
4. Ohr Pharmaceutical Announces Approval for Listing on NASDAQ
5. GDS International Leads the Way for the Pharmaceutical Industry at its Upcoming NGP DD 30 Summit in Madrid
6. PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million
7. Royalty Pharma Files Judicial Review Proceedings
8. Pointlogic and Kantar Media Announce Dedicated Communication Planning Solution for Pharmaceutical Industry
9. The Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis
10. NovoBioPharma, Partnership of Top Life Science Experts, Launches
11. Discovery Labs Presents Final Assessment in a Series of Pharmacoeconomic Analyses that Explore Impact of Reintubation on Healthcare Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... WASHINGTON , May 26, 2016 ... Microspheres, Associated With Both Cost Savings and ... BTG plc (LSE: BTG), an international specialist healthcare ... data at the 21st Annual Meeting of ISPOR ... that treatment of hepatocellular carcinoma (HCC) using yttrium-90 ...
(Date:5/25/2016)... und GERMANTOWN, Maryland , May ... mit Therawis bedient dringenden ... QIAGEN N.V. (NASDAQ: QGEN ... eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH ... Onkologie eingegangen zu sein. Ein erstes Projekt wird ...
(Date:5/25/2016)... 2016 As illustrated by the ... month, the numbers and momentum of cannabis in the ... the billions, more research and development push the sector ... of Legal Marijuana Markets Report  from from ArcView Market ... of the increase in sector is attributed to adult ...
Breaking Medicine Technology:
(Date:5/26/2016)... , ... May 26, 2016 , ... ... Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, 2016, ... public. , Dr. Maisel, founder of Retina Group of New York , ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... In an effort to provide hair restoration ... to both Snapchat users and those who do not use the app. Dr. Mohebi, the ... new page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive response ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership ... solutions, today announced the organization has earned its ISO 13485 certification, indicating the ... compliant with all rules and policies associated with ISO quality standard 13485. ...
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
(Date:5/26/2016)... ... May 26, 2016 , ... Nike Yoga Camps ... from daily practices, arts & crafts, discussions, and games all geared towards enhancing ... Evans have combined backgrounds in kids’ yoga, collegiate sport yoga instruction, and global ...
Breaking Medicine News(10 mins):